Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$428M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$232M |
| 3 |
Grayscale Bitcoin Trust
GBTC
|
+$208M |
| 4 |
Morgan Stanley Direct Lending Fund
MSDL
|
+$201M |
| 5 |
Infosys
INFY
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.9B |
| 2 |
Apple
AAPL
|
+$38.9B |
| 3 |
Amazon
AMZN
|
+$26B |
| 4 |
NVIDIA
NVDA
|
+$23.3B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.37% |
| 2 | Financials | 10.81% |
| 3 | Healthcare | 9.76% |
| 4 | Consumer Discretionary | 9.08% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBCN
5401
DELISTED
Middlefield Banc Corp
MBCN
| $300K | ﹤0.01% |
12,583
-23,343
| -65% | -$614K |
|
5402
Vor Biopharma
VOR
$1.21B
| $300K | ﹤0.01% |
6,335
-10,871
| -63% | -$477K |
|
|
AKYA
5403
DELISTED
Akoya BioSciences
AKYA
| $299K | ﹤0.01% |
63,766
-109,832
| -63% | -$570K |
|
5404
Pioneer Bancorp
PBFS
$431M
| $299K | ﹤0.01% |
30,480
-43,612
| -59% | -$417K |
|
5405
Black Diamond Therapeutics
BDTX
$102M
| $299K | ﹤0.01% |
58,898
+35,236
| +149% | +$142K |
|
|
EMX
5406
DELISTED
EMX Royalty
EMX
| $298K | ﹤0.01% |
173,025
-343,967
| -67% | -$544K |
|
5407
TELA Bio
TELA
$40.6M
| $297K | ﹤0.01% |
52,393
-128,049
| -71% | -$844K |
|
5408
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE
$14.7M
| $297K | ﹤0.01% |
7,180
-7,240
| -50% | -$300K |
|
5409
Waldencast
WALD
$198M
| $296K | ﹤0.01% |
45,594
-103,920
| -70% | -$800K |
|
5410
Solid Biosciences
SLDB
$849M
| $296K | ﹤0.01% |
22,185
+13,719
| +162% | +$128K |
|
|
AMLI
5411
DELISTED
American Lithium Corp. Common Stock
AMLI
| $294K | ﹤0.01% |
433,069
-374,469
| -46% | -$319K |
|
5412
Better Home & Finance Holding
BETR
$326M
| $294K | ﹤0.01% |
11,844
-11,844
| -50% | -$332K |
|
5413
Comtech Telecommunications
CMTL
$50.6M
| $292K | ﹤0.01% |
85,127
-271,423
| -76% | -$1.7M |
|
5414
Vuzix
VUZI
$220M
| $291K | ﹤0.01% |
240,571
-602,599
| -71% | -$983K |
|
|
JEQ
5415
DELISTED
abrdn Japan Equity Fund
JEQ
| $291K | ﹤0.01% |
46,715
-97,029
| -68% | -$585K |
|
5416
Cibus
CBUS
$147M
| $291K | ﹤0.01% |
12,944
-15,466
| -54% | -$284K |
|
5417
SoundThinking
SSTI
$107M
| $290K | ﹤0.01% |
18,276
-33,630
| -65% | -$642K |
|
|
FIRY
5418
Firy Inc
FIRY
$146M
| $290K | ﹤0.01% |
44,713
-62,765
| -58% | -$385K |
|
|
BFIN
5419
DELISTED
BankFinancial
BFIN
| $290K | ﹤0.01% |
27,572
-27,250
| -50% | -$280K |
|
5420
JPMorgan BetaBuilders USD Investment Grade Corporate Bond ETF
BBCB
$45.7M
| $289K | ﹤0.01% |
6,358
-4,486
| -41% | -$204K |
|
5421
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
$292M
| $289K | ﹤0.01% |
7,720
-5,812
| -43% | -$210K |
|
5422
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.49B
| $289K | ﹤0.01% |
13,576
-16,144
| -54% | -$329K |
|
5423
Bank7 Corp
BSVN
$486M
| $288K | ﹤0.01% |
10,226
-12,790
| -56% | -$345K |
|
5424
PDS Biotechnology
PDSB
$40.3M
| $288K | ﹤0.01% |
72,771
-97,521
| -57% | -$502K |
|
5425
908 Devices
MASS
$347M
| $287K | ﹤0.01% |
38,011
-102,639
| -73% | -$761K |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
- Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
- Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.